nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—Betaxolol—glaucoma	0.0884	0.646	CbGbCtD
Rasagiline—CYP1A2—Clonidine—glaucoma	0.0484	0.354	CbGbCtD
Rasagiline—BCL2—The NLRP1 inflammasome—BCL2L1—glaucoma	0.0138	0.058	CbGpPWpGaD
Rasagiline—BCL2—Treprostinil—Latanoprost—glaucoma	0.00915	1	CbGdCrCtD
Rasagiline—BCL2—Inflammasomes—TXNIP—glaucoma	0.00914	0.0385	CbGpPWpGaD
Rasagiline—BCL2—Inflammasomes—TXN—glaucoma	0.00723	0.0305	CbGpPWpGaD
Rasagiline—BCL2—BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members—BCL2L1—glaucoma	0.00629	0.0265	CbGpPWpGaD
Rasagiline—MAOB—Dopamine metabolism—SOD1—glaucoma	0.00578	0.0244	CbGpPWpGaD
Rasagiline—BCL2—BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members—BAD—glaucoma	0.0057	0.024	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—BECN1—glaucoma	0.00518	0.0218	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—POU4F2—glaucoma	0.00484	0.0204	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TXNIP—glaucoma	0.00439	0.0185	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00362	0.0153	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CA1—glaucoma	0.00356	0.015	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TXN—glaucoma	0.00347	0.0146	CbGpPWpGaD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—BAD—glaucoma	0.00345	0.0145	CbGpPWpGaD
Rasagiline—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00322	0.0136	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00321	0.0135	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—CCND2—glaucoma	0.00304	0.0128	CbGpPWpGaD
Rasagiline—BCL2—Inflammasomes—BCL2L1—glaucoma	0.00302	0.0127	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—FN1—glaucoma	0.00289	0.0122	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—POU4F1—glaucoma	0.00265	0.0112	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—SOD1—glaucoma	0.00238	0.01	CbGpPWpGaD
Rasagiline—MAOB—Tryptophan metabolism—CYP1B1—glaucoma	0.00236	0.00995	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—CCND2—glaucoma	0.00232	0.00977	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—BAD—glaucoma	0.00229	0.00965	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—CDKN2A—glaucoma	0.00224	0.00945	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00221	0.00933	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—TGFB2—glaucoma	0.00221	0.00931	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—BCL2L1—glaucoma	0.00218	0.0092	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—COL11A1—glaucoma	0.00218	0.00918	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—glaucoma	0.00214	0.00903	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—PTGS2—glaucoma	0.0021	0.00883	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—BCL2L1—glaucoma	0.00207	0.00874	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00202	0.00849	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—CDKN2B—glaucoma	0.002	0.00844	CbGpPWpGaD
Rasagiline—MAOB—Alpha-synuclein signaling—BAD—glaucoma	0.00198	0.00836	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—IL1A—glaucoma	0.00198	0.00836	CbGpPWpGaD
Rasagiline—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00197	0.0083	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—BCL2L1—glaucoma	0.00185	0.00778	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—BCL2L1—glaucoma	0.00181	0.00761	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—BCL2L1—glaucoma	0.00181	0.00761	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—FAS—glaucoma	0.00177	0.00745	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CAV2—glaucoma	0.00165	0.00696	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—BAD—glaucoma	0.00164	0.0069	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—BAD—glaucoma	0.00164	0.0069	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—MMP1—glaucoma	0.00162	0.00681	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00155	0.00652	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—CDKN2B—glaucoma	0.0015	0.00633	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.0015	0.00633	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MYLK—glaucoma	0.00148	0.00624	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—BCL2L1—glaucoma	0.00147	0.00621	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—BAD—glaucoma	0.00146	0.00614	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—BCL2L1—glaucoma	0.00145	0.00611	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—glaucoma	0.00142	0.00596	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—FAS—glaucoma	0.00138	0.00583	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BCL2L1—glaucoma	0.00136	0.00575	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—BAD—glaucoma	0.00136	0.00572	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—BAD—glaucoma	0.00134	0.00563	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—BCL2L1—glaucoma	0.00131	0.00551	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—BAD—glaucoma	0.00129	0.00545	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—BCL2L1—glaucoma	0.00127	0.00536	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—glaucoma	0.00125	0.00526	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BAD—glaucoma	0.00124	0.00521	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.00116	0.00488	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—BAD—glaucoma	0.00115	0.00485	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—GSTM1—glaucoma	0.00113	0.00477	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.0011	0.00464	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CCND2—glaucoma	0.00108	0.00456	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTT1—glaucoma	0.00103	0.00435	CbGpPWpGaD
Rasagiline—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.00102	0.00431	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—FAS—glaucoma	0.00102	0.00428	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—CDKN1B—glaucoma	0.00101	0.00427	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—glaucoma	0.001	0.00422	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—MMP2—glaucoma	0.000989	0.00417	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BCL2L1—glaucoma	0.000958	0.00404	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1A—glaucoma	0.000953	0.00401	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—FAS—glaucoma	0.000952	0.00401	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000925	0.0039	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—glaucoma	0.00091	0.00383	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000901	0.0038	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—BCL2L1—glaucoma	0.000899	0.00379	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BAD—glaucoma	0.000868	0.00366	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP1B1—glaucoma	0.000822	0.00346	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—BAD—glaucoma	0.000814	0.00343	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—glaucoma	0.000813	0.00343	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00079	0.00333	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—CDKN1B—glaucoma	0.000761	0.00321	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—glaucoma	0.00075	0.00316	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—FN1—glaucoma	0.000735	0.0031	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CA5A—glaucoma	0.000723	0.00305	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NARFL—glaucoma	0.000723	0.00305	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—glaucoma	0.000717	0.00302	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—glaucoma	0.000717	0.00302	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—BAD—glaucoma	0.000705	0.00297	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000696	0.00293	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CCND2—glaucoma	0.000693	0.00292	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CDKN2A—glaucoma	0.000683	0.00288	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CDKN2A—glaucoma	0.000683	0.00288	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—FAS—glaucoma	0.000675	0.00284	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—glaucoma	0.000674	0.00284	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000672	0.00283	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTM1—glaucoma	0.000657	0.00277	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—NOS3—glaucoma	0.000649	0.00273	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CDKN2A—glaucoma	0.00064	0.0027	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000639	0.00269	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—glaucoma	0.000638	0.00269	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—glaucoma	0.000637	0.00269	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—BCL2L1—glaucoma	0.000637	0.00268	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—FAS—glaucoma	0.000622	0.00262	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TXNIP—glaucoma	0.000621	0.00262	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000619	0.00261	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000615	0.00259	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—CAV1—glaucoma	0.000614	0.00258	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TBK1—glaucoma	0.000609	0.00257	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CDKN1B—glaucoma	0.000605	0.00255	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000602	0.00254	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—glaucoma	0.000588	0.00248	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BCL2L1—glaucoma	0.000587	0.00247	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CDKN2A—glaucoma	0.000571	0.00241	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—glaucoma	0.000554	0.00234	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—C1QB—glaucoma	0.000551	0.00232	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000546	0.0023	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000546	0.0023	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000546	0.0023	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000543	0.00229	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BAD—glaucoma	0.000532	0.00224	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000526	0.00222	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.00052	0.00219	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000511	0.00215	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.000506	0.00213	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MMP2—glaucoma	0.000495	0.00209	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CDKN1B—glaucoma	0.000491	0.00207	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TXN—glaucoma	0.000491	0.00207	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CAV1—glaucoma	0.000481	0.00202	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—FN1—glaucoma	0.000457	0.00193	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—BAD—glaucoma	0.000452	0.0019	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00045	0.0019	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000442	0.00186	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000436	0.00184	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—glaucoma	0.000431	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSA—glaucoma	0.00043	0.00181	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000408	0.00172	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—glaucoma	0.00038	0.0016	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TXNIP—glaucoma	0.000362	0.00152	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000358	0.00151	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—glaucoma	0.000356	0.0015	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TBK1—glaucoma	0.000355	0.00149	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CA1—glaucoma	0.000353	0.00149	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CTSA—glaucoma	0.000342	0.00144	CbGpPWpGaD
Rasagiline—Body temperature increased—Acetazolamide—glaucoma	0.000332	0.000538	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000331	0.000538	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Travoprost—glaucoma	0.000331	0.000537	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000331	0.00139	CbGpPWpGaD
Rasagiline—Cardiac disorder—Betaxolol—glaucoma	0.00033	0.000536	CcSEcCtD
Rasagiline—Ill-defined disorder—Clonidine—glaucoma	0.00033	0.000536	CcSEcCtD
Rasagiline—Insomnia—Pilocarpine—glaucoma	0.000329	0.000534	CcSEcCtD
Rasagiline—Decreased appetite—Brinzolamide—glaucoma	0.000329	0.000534	CcSEcCtD
Rasagiline—Weight decreased—Timolol—glaucoma	0.000329	0.000533	CcSEcCtD
Rasagiline—Constipation—Travoprost—glaucoma	0.000328	0.000532	CcSEcCtD
Rasagiline—Agitation—Clonidine—glaucoma	0.000327	0.000531	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000327	0.00053	CcSEcCtD
Rasagiline—Paraesthesia—Pilocarpine—glaucoma	0.000327	0.00053	CcSEcCtD
Rasagiline—Asthenia—Bimatoprost—glaucoma	0.000327	0.00053	CcSEcCtD
Rasagiline—Dyspnoea—Pilocarpine—glaucoma	0.000324	0.000526	CcSEcCtD
Rasagiline—Somnolence—Pilocarpine—glaucoma	0.000323	0.000524	CcSEcCtD
Rasagiline—Depression—Timolol—glaucoma	0.000323	0.000524	CcSEcCtD
Rasagiline—Angiopathy—Betaxolol—glaucoma	0.000323	0.000524	CcSEcCtD
Rasagiline—MAOB—Metabolism—CA2—glaucoma	0.000323	0.00136	CbGpPWpGaD
Rasagiline—Pruritus—Bimatoprost—glaucoma	0.000322	0.000522	CcSEcCtD
Rasagiline—Immune system disorder—Betaxolol—glaucoma	0.000322	0.000521	CcSEcCtD
Rasagiline—Diarrhoea—Apraclonidine—glaucoma	0.000321	0.000521	CcSEcCtD
Rasagiline—Malaise—Clonidine—glaucoma	0.000321	0.000521	CcSEcCtD
Rasagiline—Mediastinal disorder—Betaxolol—glaucoma	0.000321	0.00052	CcSEcCtD
Rasagiline—BCL2—Immune System—C1QB—glaucoma	0.000321	0.00135	CbGpPWpGaD
Rasagiline—Dyspepsia—Pilocarpine—glaucoma	0.00032	0.000519	CcSEcCtD
Rasagiline—Chills—Betaxolol—glaucoma	0.000319	0.000518	CcSEcCtD
Rasagiline—Syncope—Clonidine—glaucoma	0.000319	0.000518	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000318	0.00134	CbGpPWpGaD
Rasagiline—Feeling abnormal—Dorzolamide—glaucoma	0.000317	0.000515	CcSEcCtD
Rasagiline—Decreased appetite—Pilocarpine—glaucoma	0.000316	0.000513	CcSEcCtD
Rasagiline—Feeling abnormal—Travoprost—glaucoma	0.000316	0.000512	CcSEcCtD
Rasagiline—Conjunctivitis—Timolol—glaucoma	0.000315	0.000511	CcSEcCtD
Rasagiline—Gastrointestinal pain—Dorzolamide—glaucoma	0.000315	0.000511	CcSEcCtD
Rasagiline—Alopecia—Betaxolol—glaucoma	0.000315	0.00051	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000315	0.00133	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000314	0.000509	CcSEcCtD
Rasagiline—Gastrointestinal pain—Travoprost—glaucoma	0.000313	0.000508	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000313	0.00132	CbGpPWpGaD
Rasagiline—Loss of consciousness—Clonidine—glaucoma	0.000313	0.000507	CcSEcCtD
Rasagiline—Feeling abnormal—Brinzolamide—glaucoma	0.000312	0.000506	CcSEcCtD
Rasagiline—Mental disorder—Betaxolol—glaucoma	0.000312	0.000506	CcSEcCtD
Rasagiline—Constipation—Pilocarpine—glaucoma	0.000311	0.000505	CcSEcCtD
Rasagiline—Cough—Clonidine—glaucoma	0.000311	0.000504	CcSEcCtD
Rasagiline—Sweating—Timolol—glaucoma	0.000311	0.000504	CcSEcCtD
Rasagiline—Dizziness—Apraclonidine—glaucoma	0.000311	0.000504	CcSEcCtD
Rasagiline—Malnutrition—Betaxolol—glaucoma	0.00031	0.000503	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—glaucoma	0.000309	0.0013	CbGpPWpGaD
Rasagiline—Urticaria—Dorzolamide—glaucoma	0.000306	0.000496	CcSEcCtD
Rasagiline—Epistaxis—Timolol—glaucoma	0.000306	0.000496	CcSEcCtD
Rasagiline—Abdominal pain—Dorzolamide—glaucoma	0.000304	0.000494	CcSEcCtD
Rasagiline—Body temperature increased—Dorzolamide—glaucoma	0.000304	0.000494	CcSEcCtD
Rasagiline—Dysgeusia—Betaxolol—glaucoma	0.000304	0.000492	CcSEcCtD
Rasagiline—Chest pain—Clonidine—glaucoma	0.000303	0.000491	CcSEcCtD
Rasagiline—Arthralgia—Clonidine—glaucoma	0.000303	0.000491	CcSEcCtD
Rasagiline—Abdominal pain—Travoprost—glaucoma	0.000303	0.000491	CcSEcCtD
Rasagiline—Anxiety—Clonidine—glaucoma	0.000302	0.00049	CcSEcCtD
Rasagiline—Asthenia—Acetazolamide—glaucoma	0.000301	0.000489	CcSEcCtD
Rasagiline—Dizziness—Bimatoprost—glaucoma	0.000301	0.000488	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000301	0.000488	CcSEcCtD
Rasagiline—Urticaria—Brinzolamide—glaucoma	0.000301	0.000488	CcSEcCtD
Rasagiline—Feeling abnormal—Pilocarpine—glaucoma	0.0003	0.000486	CcSEcCtD
Rasagiline—Discomfort—Clonidine—glaucoma	0.000299	0.000486	CcSEcCtD
Rasagiline—Vomiting—Apraclonidine—glaucoma	0.000299	0.000484	CcSEcCtD
Rasagiline—Muscle spasms—Betaxolol—glaucoma	0.000298	0.000483	CcSEcCtD
Rasagiline—Gastrointestinal pain—Pilocarpine—glaucoma	0.000298	0.000482	CcSEcCtD
Rasagiline—Hypersensitivity—Brimonidine—glaucoma	0.000297	0.000482	CcSEcCtD
Rasagiline—Dry mouth—Clonidine—glaucoma	0.000296	0.000481	CcSEcCtD
Rasagiline—Dermatitis—Apraclonidine—glaucoma	0.000296	0.00048	CcSEcCtD
Rasagiline—Headache—Apraclonidine—glaucoma	0.000294	0.000477	CcSEcCtD
Rasagiline—Confusional state—Clonidine—glaucoma	0.000293	0.000475	CcSEcCtD
Rasagiline—Rhinitis—Timolol—glaucoma	0.000292	0.000473	CcSEcCtD
Rasagiline—Tremor—Betaxolol—glaucoma	0.00029	0.000471	CcSEcCtD
Rasagiline—Hallucination—Timolol—glaucoma	0.000289	0.000469	CcSEcCtD
Rasagiline—Asthenia—Brimonidine—glaucoma	0.000289	0.000469	CcSEcCtD
Rasagiline—Infection—Clonidine—glaucoma	0.000289	0.000468	CcSEcCtD
Rasagiline—Abdominal pain—Pilocarpine—glaucoma	0.000288	0.000466	CcSEcCtD
Rasagiline—Body temperature increased—Pilocarpine—glaucoma	0.000288	0.000466	CcSEcCtD
Rasagiline—Ill-defined disorder—Betaxolol—glaucoma	0.000288	0.000466	CcSEcCtD
Rasagiline—Diarrhoea—Acetazolamide—glaucoma	0.000287	0.000466	CcSEcCtD
Rasagiline—Rash—Bimatoprost—glaucoma	0.000287	0.000466	CcSEcCtD
Rasagiline—Dermatitis—Bimatoprost—glaucoma	0.000287	0.000465	CcSEcCtD
Rasagiline—Oedema peripheral—Timolol—glaucoma	0.000287	0.000465	CcSEcCtD
Rasagiline—Anaemia—Betaxolol—glaucoma	0.000286	0.000465	CcSEcCtD
Rasagiline—BCL2—Immune System—TXN—glaucoma	0.000286	0.0012	CbGpPWpGaD
Rasagiline—Shock—Clonidine—glaucoma	0.000286	0.000464	CcSEcCtD
Rasagiline—Connective tissue disorder—Timolol—glaucoma	0.000286	0.000463	CcSEcCtD
Rasagiline—Pruritus—Brimonidine—glaucoma	0.000285	0.000463	CcSEcCtD
Rasagiline—Headache—Bimatoprost—glaucoma	0.000285	0.000463	CcSEcCtD
Rasagiline—Nervous system disorder—Clonidine—glaucoma	0.000285	0.000462	CcSEcCtD
Rasagiline—Hypersensitivity—Dorzolamide—glaucoma	0.000284	0.00046	CcSEcCtD
Rasagiline—Hypersensitivity—Travoprost—glaucoma	0.000282	0.000458	CcSEcCtD
Rasagiline—Skin disorder—Clonidine—glaucoma	0.000282	0.000458	CcSEcCtD
Rasagiline—Hyperhidrosis—Clonidine—glaucoma	0.000281	0.000455	CcSEcCtD
Rasagiline—Malaise—Betaxolol—glaucoma	0.00028	0.000453	CcSEcCtD
Rasagiline—Nausea—Apraclonidine—glaucoma	0.000279	0.000452	CcSEcCtD
Rasagiline—Hypersensitivity—Brinzolamide—glaucoma	0.000279	0.000452	CcSEcCtD
Rasagiline—Vertigo—Betaxolol—glaucoma	0.000278	0.000452	CcSEcCtD
Rasagiline—Syncope—Betaxolol—glaucoma	0.000278	0.000451	CcSEcCtD
Rasagiline—Dizziness—Acetazolamide—glaucoma	0.000278	0.00045	CcSEcCtD
Rasagiline—Anorexia—Clonidine—glaucoma	0.000277	0.000449	CcSEcCtD
Rasagiline—Asthenia—Dorzolamide—glaucoma	0.000276	0.000448	CcSEcCtD
Rasagiline—Asthenia—Travoprost—glaucoma	0.000275	0.000446	CcSEcCtD
Rasagiline—Pruritus—Dorzolamide—glaucoma	0.000272	0.000442	CcSEcCtD
Rasagiline—Loss of consciousness—Betaxolol—glaucoma	0.000272	0.000442	CcSEcCtD
Rasagiline—Eye disorder—Timolol—glaucoma	0.000272	0.000441	CcSEcCtD
Rasagiline—Asthenia—Brinzolamide—glaucoma	0.000272	0.00044	CcSEcCtD
Rasagiline—Hypotension—Clonidine—glaucoma	0.000271	0.00044	CcSEcCtD
Rasagiline—Pruritus—Travoprost—glaucoma	0.000271	0.00044	CcSEcCtD
Rasagiline—Cough—Betaxolol—glaucoma	0.00027	0.000439	CcSEcCtD
Rasagiline—Nausea—Bimatoprost—glaucoma	0.00027	0.000439	CcSEcCtD
Rasagiline—Cardiac disorder—Timolol—glaucoma	0.00027	0.000438	CcSEcCtD
Rasagiline—Hypersensitivity—Pilocarpine—glaucoma	0.000268	0.000435	CcSEcCtD
Rasagiline—Pruritus—Brinzolamide—glaucoma	0.000268	0.000434	CcSEcCtD
Rasagiline—Vomiting—Acetazolamide—glaucoma	0.000267	0.000433	CcSEcCtD
Rasagiline—Dizziness—Brimonidine—glaucoma	0.000267	0.000432	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Clonidine—glaucoma	0.000265	0.000429	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—glaucoma	0.000264	0.00111	CbGpPWpGaD
Rasagiline—Angiopathy—Timolol—glaucoma	0.000264	0.000428	CcSEcCtD
Rasagiline—Arthralgia—Betaxolol—glaucoma	0.000264	0.000428	CcSEcCtD
Rasagiline—Chest pain—Betaxolol—glaucoma	0.000264	0.000428	CcSEcCtD
Rasagiline—Diarrhoea—Dorzolamide—glaucoma	0.000263	0.000427	CcSEcCtD
Rasagiline—Headache—Acetazolamide—glaucoma	0.000263	0.000427	CcSEcCtD
Rasagiline—Anxiety—Betaxolol—glaucoma	0.000263	0.000426	CcSEcCtD
Rasagiline—Insomnia—Clonidine—glaucoma	0.000263	0.000426	CcSEcCtD
Rasagiline—Immune system disorder—Timolol—glaucoma	0.000263	0.000426	CcSEcCtD
Rasagiline—Diarrhoea—Travoprost—glaucoma	0.000262	0.000425	CcSEcCtD
Rasagiline—Mediastinal disorder—Timolol—glaucoma	0.000262	0.000425	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000262	0.000425	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VEGFA—glaucoma	0.000262	0.0011	CbGpPWpGaD
Rasagiline—Asthenia—Pilocarpine—glaucoma	0.000261	0.000423	CcSEcCtD
Rasagiline—Paraesthesia—Clonidine—glaucoma	0.000261	0.000423	CcSEcCtD
Rasagiline—Discomfort—Betaxolol—glaucoma	0.000261	0.000423	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000261	0.0011	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.00026	0.0011	CbGpPWpGaD
Rasagiline—Dyspnoea—Clonidine—glaucoma	0.000259	0.00042	CcSEcCtD
Rasagiline—Diarrhoea—Brinzolamide—glaucoma	0.000259	0.00042	CcSEcCtD
Rasagiline—Somnolence—Clonidine—glaucoma	0.000258	0.000419	CcSEcCtD
Rasagiline—Dry mouth—Betaxolol—glaucoma	0.000258	0.000418	CcSEcCtD
Rasagiline—Pruritus—Pilocarpine—glaucoma	0.000257	0.000417	CcSEcCtD
Rasagiline—Alopecia—Timolol—glaucoma	0.000257	0.000417	CcSEcCtD
Rasagiline—Confusional state—Betaxolol—glaucoma	0.000255	0.000414	CcSEcCtD
Rasagiline—Mental disorder—Timolol—glaucoma	0.000255	0.000413	CcSEcCtD
Rasagiline—Dizziness—Dorzolamide—glaucoma	0.000255	0.000413	CcSEcCtD
Rasagiline—Rash—Brimonidine—glaucoma	0.000254	0.000412	CcSEcCtD
Rasagiline—Dermatitis—Brimonidine—glaucoma	0.000254	0.000412	CcSEcCtD
Rasagiline—Dizziness—Travoprost—glaucoma	0.000254	0.000411	CcSEcCtD
Rasagiline—Malnutrition—Timolol—glaucoma	0.000253	0.000411	CcSEcCtD
Rasagiline—Headache—Brimonidine—glaucoma	0.000253	0.00041	CcSEcCtD
Rasagiline—Decreased appetite—Clonidine—glaucoma	0.000253	0.00041	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—TP53—glaucoma	0.000253	0.00106	CbGpPWpGaD
Rasagiline—Infection—Betaxolol—glaucoma	0.000251	0.000408	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Clonidine—glaucoma	0.000251	0.000407	CcSEcCtD
Rasagiline—Dizziness—Brinzolamide—glaucoma	0.00025	0.000406	CcSEcCtD
Rasagiline—Nausea—Acetazolamide—glaucoma	0.00025	0.000405	CcSEcCtD
Rasagiline—Diarrhoea—Pilocarpine—glaucoma	0.000249	0.000404	CcSEcCtD
Rasagiline—Shock—Betaxolol—glaucoma	0.000249	0.000404	CcSEcCtD
Rasagiline—Constipation—Clonidine—glaucoma	0.000248	0.000403	CcSEcCtD
Rasagiline—Nervous system disorder—Betaxolol—glaucoma	0.000248	0.000402	CcSEcCtD
Rasagiline—Dysgeusia—Timolol—glaucoma	0.000248	0.000402	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000246	0.00104	CbGpPWpGaD
Rasagiline—Skin disorder—Betaxolol—glaucoma	0.000246	0.000398	CcSEcCtD
Rasagiline—Vomiting—Dorzolamide—glaucoma	0.000245	0.000397	CcSEcCtD
Rasagiline—Hyperhidrosis—Betaxolol—glaucoma	0.000245	0.000397	CcSEcCtD
Rasagiline—Rash—Dorzolamide—glaucoma	0.000243	0.000394	CcSEcCtD
Rasagiline—Dermatitis—Dorzolamide—glaucoma	0.000243	0.000393	CcSEcCtD
Rasagiline—Rash—Travoprost—glaucoma	0.000242	0.000392	CcSEcCtD
Rasagiline—Dermatitis—Travoprost—glaucoma	0.000242	0.000392	CcSEcCtD
Rasagiline—Headache—Dorzolamide—glaucoma	0.000241	0.000391	CcSEcCtD
Rasagiline—Anorexia—Betaxolol—glaucoma	0.000241	0.000391	CcSEcCtD
Rasagiline—Vomiting—Brinzolamide—glaucoma	0.000241	0.00039	CcSEcCtD
Rasagiline—Dizziness—Pilocarpine—glaucoma	0.000241	0.00039	CcSEcCtD
Rasagiline—Headache—Travoprost—glaucoma	0.00024	0.000389	CcSEcCtD
Rasagiline—Nausea—Brimonidine—glaucoma	0.000239	0.000388	CcSEcCtD
Rasagiline—Feeling abnormal—Clonidine—glaucoma	0.000239	0.000388	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000239	0.00101	CbGpPWpGaD
Rasagiline—Rash—Brinzolamide—glaucoma	0.000239	0.000387	CcSEcCtD
Rasagiline—Dermatitis—Brinzolamide—glaucoma	0.000238	0.000387	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000238	0.001	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Clonidine—glaucoma	0.000238	0.000385	CcSEcCtD
Rasagiline—Headache—Brinzolamide—glaucoma	0.000237	0.000385	CcSEcCtD
Rasagiline—Hypotension—Betaxolol—glaucoma	0.000236	0.000383	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000233	0.000983	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000233	0.000983	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—glaucoma	0.000233	0.000981	CbGpPWpGaD
Rasagiline—Vomiting—Pilocarpine—glaucoma	0.000231	0.000375	CcSEcCtD
Rasagiline—Urticaria—Clonidine—glaucoma	0.000231	0.000374	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00023	0.000374	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.00023	0.00097	CbGpPWpGaD
Rasagiline—Abdominal pain—Clonidine—glaucoma	0.00023	0.000372	CcSEcCtD
Rasagiline—Body temperature increased—Clonidine—glaucoma	0.00023	0.000372	CcSEcCtD
Rasagiline—Rash—Pilocarpine—glaucoma	0.000229	0.000372	CcSEcCtD
Rasagiline—Dermatitis—Pilocarpine—glaucoma	0.000229	0.000372	CcSEcCtD
Rasagiline—Insomnia—Betaxolol—glaucoma	0.000229	0.000371	CcSEcCtD
Rasagiline—Nausea—Dorzolamide—glaucoma	0.000229	0.000371	CcSEcCtD
Rasagiline—Headache—Pilocarpine—glaucoma	0.000228	0.00037	CcSEcCtD
Rasagiline—Nausea—Travoprost—glaucoma	0.000228	0.000369	CcSEcCtD
Rasagiline—MAOB—Metabolism—TXN—glaucoma	0.000228	0.000959	CbGpPWpGaD
Rasagiline—Vertigo—Timolol—glaucoma	0.000227	0.000369	CcSEcCtD
Rasagiline—Paraesthesia—Betaxolol—glaucoma	0.000227	0.000368	CcSEcCtD
Rasagiline—Syncope—Timolol—glaucoma	0.000227	0.000368	CcSEcCtD
Rasagiline—Dyspnoea—Betaxolol—glaucoma	0.000226	0.000366	CcSEcCtD
Rasagiline—Nausea—Brinzolamide—glaucoma	0.000225	0.000365	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000223	0.000941	CbGpPWpGaD
Rasagiline—Dyspepsia—Betaxolol—glaucoma	0.000223	0.000361	CcSEcCtD
Rasagiline—Loss of consciousness—Timolol—glaucoma	0.000223	0.000361	CcSEcCtD
Rasagiline—Cough—Timolol—glaucoma	0.000221	0.000358	CcSEcCtD
Rasagiline—Decreased appetite—Betaxolol—glaucoma	0.00022	0.000357	CcSEcCtD
Rasagiline—Hypertension—Timolol—glaucoma	0.000219	0.000354	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Betaxolol—glaucoma	0.000218	0.000354	CcSEcCtD
Rasagiline—Constipation—Betaxolol—glaucoma	0.000216	0.000351	CcSEcCtD
Rasagiline—Nausea—Pilocarpine—glaucoma	0.000216	0.00035	CcSEcCtD
Rasagiline—Chest pain—Timolol—glaucoma	0.000216	0.00035	CcSEcCtD
Rasagiline—Arthralgia—Timolol—glaucoma	0.000216	0.00035	CcSEcCtD
Rasagiline—Anxiety—Timolol—glaucoma	0.000215	0.000348	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—C3—glaucoma	0.000214	0.000903	CbGpPWpGaD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000214	0.000347	CcSEcCtD
Rasagiline—Hypersensitivity—Clonidine—glaucoma	0.000214	0.000347	CcSEcCtD
Rasagiline—Discomfort—Timolol—glaucoma	0.000213	0.000345	CcSEcCtD
Rasagiline—Dry mouth—Timolol—glaucoma	0.000211	0.000342	CcSEcCtD
Rasagiline—Asthenia—Clonidine—glaucoma	0.000208	0.000338	CcSEcCtD
Rasagiline—Feeling abnormal—Betaxolol—glaucoma	0.000208	0.000338	CcSEcCtD
Rasagiline—Confusional state—Timolol—glaucoma	0.000208	0.000338	CcSEcCtD
Rasagiline—Pruritus—Clonidine—glaucoma	0.000206	0.000333	CcSEcCtD
Rasagiline—Infection—Timolol—glaucoma	0.000205	0.000333	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—BCL2L1—glaucoma	0.000205	0.000864	CbGpPWpGaD
Rasagiline—Shock—Timolol—glaucoma	0.000203	0.00033	CcSEcCtD
Rasagiline—Nervous system disorder—Timolol—glaucoma	0.000203	0.000329	CcSEcCtD
Rasagiline—Urticaria—Betaxolol—glaucoma	0.000201	0.000326	CcSEcCtD
Rasagiline—Skin disorder—Timolol—glaucoma	0.000201	0.000325	CcSEcCtD
Rasagiline—Body temperature increased—Betaxolol—glaucoma	0.0002	0.000324	CcSEcCtD
Rasagiline—Hyperhidrosis—Timolol—glaucoma	0.0002	0.000324	CcSEcCtD
Rasagiline—Diarrhoea—Clonidine—glaucoma	0.000199	0.000322	CcSEcCtD
Rasagiline—Anorexia—Timolol—glaucoma	0.000197	0.000319	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000197	0.00083	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000194	0.000817	CbGpPWpGaD
Rasagiline—Hypotension—Timolol—glaucoma	0.000193	0.000313	CcSEcCtD
Rasagiline—Dizziness—Clonidine—glaucoma	0.000192	0.000312	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.00019	0.000801	CbGpPWpGaD
Rasagiline—Musculoskeletal discomfort—Timolol—glaucoma	0.000188	0.000305	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000188	0.00079	CbGpPWpGaD
Rasagiline—Insomnia—Timolol—glaucoma	0.000187	0.000303	CcSEcCtD
Rasagiline—Hypersensitivity—Betaxolol—glaucoma	0.000186	0.000302	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—BAD—glaucoma	0.000186	0.000783	CbGpPWpGaD
Rasagiline—Paraesthesia—Timolol—glaucoma	0.000186	0.000301	CcSEcCtD
Rasagiline—Vomiting—Clonidine—glaucoma	0.000185	0.0003	CcSEcCtD
Rasagiline—Dyspnoea—Timolol—glaucoma	0.000184	0.000299	CcSEcCtD
Rasagiline—Somnolence—Timolol—glaucoma	0.000184	0.000298	CcSEcCtD
Rasagiline—Rash—Clonidine—glaucoma	0.000183	0.000297	CcSEcCtD
Rasagiline—Dermatitis—Clonidine—glaucoma	0.000183	0.000297	CcSEcCtD
Rasagiline—Headache—Clonidine—glaucoma	0.000182	0.000295	CcSEcCtD
Rasagiline—Dyspepsia—Timolol—glaucoma	0.000182	0.000295	CcSEcCtD
Rasagiline—Asthenia—Betaxolol—glaucoma	0.000181	0.000294	CcSEcCtD
Rasagiline—Decreased appetite—Timolol—glaucoma	0.00018	0.000291	CcSEcCtD
Rasagiline—Pruritus—Betaxolol—glaucoma	0.000179	0.00029	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Timolol—glaucoma	0.000178	0.000289	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000178	0.000749	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTT1—glaucoma	0.000176	0.000743	CbGpPWpGaD
Rasagiline—Diarrhoea—Betaxolol—glaucoma	0.000173	0.000281	CcSEcCtD
Rasagiline—Nausea—Clonidine—glaucoma	0.000173	0.00028	CcSEcCtD
Rasagiline—Feeling abnormal—Timolol—glaucoma	0.00017	0.000276	CcSEcCtD
Rasagiline—Gastrointestinal pain—Timolol—glaucoma	0.000169	0.000274	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—NARFL—glaucoma	0.000167	0.000705	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA5A—glaucoma	0.000167	0.000705	CbGpPWpGaD
Rasagiline—Dizziness—Betaxolol—glaucoma	0.000167	0.000271	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000166	0.0007	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000166	0.0007	CbGpPWpGaD
Rasagiline—Urticaria—Timolol—glaucoma	0.000164	0.000266	CcSEcCtD
Rasagiline—Abdominal pain—Timolol—glaucoma	0.000163	0.000265	CcSEcCtD
Rasagiline—Body temperature increased—Timolol—glaucoma	0.000163	0.000265	CcSEcCtD
Rasagiline—Vomiting—Betaxolol—glaucoma	0.000161	0.000261	CcSEcCtD
Rasagiline—Rash—Betaxolol—glaucoma	0.000159	0.000259	CcSEcCtD
Rasagiline—Dermatitis—Betaxolol—glaucoma	0.000159	0.000258	CcSEcCtD
Rasagiline—Headache—Betaxolol—glaucoma	0.000158	0.000257	CcSEcCtD
Rasagiline—Hypersensitivity—Timolol—glaucoma	0.000152	0.000247	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—glaucoma	0.000152	0.000641	CbGpPWpGaD
Rasagiline—Nausea—Betaxolol—glaucoma	0.00015	0.000244	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	0.00015	0.000632	CbGpPWpGaD
Rasagiline—Asthenia—Timolol—glaucoma	0.000148	0.00024	CcSEcCtD
Rasagiline—Pruritus—Timolol—glaucoma	0.000146	0.000237	CcSEcCtD
Rasagiline—BCL2—Immune System—IL1A—glaucoma	0.000142	0.000598	CbGpPWpGaD
Rasagiline—Diarrhoea—Timolol—glaucoma	0.000141	0.000229	CcSEcCtD
Rasagiline—MAOB—Metabolism—ABCA1—glaucoma	0.000141	0.000592	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1B1—glaucoma	0.000141	0.000592	CbGpPWpGaD
Rasagiline—Dizziness—Timolol—glaucoma	0.000137	0.000222	CcSEcCtD
Rasagiline—Vomiting—Timolol—glaucoma	0.000131	0.000213	CcSEcCtD
Rasagiline—Rash—Timolol—glaucoma	0.00013	0.000211	CcSEcCtD
Rasagiline—Dermatitis—Timolol—glaucoma	0.00013	0.000211	CcSEcCtD
Rasagiline—Headache—Timolol—glaucoma	0.000129	0.00021	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CDKN1B—glaucoma	0.000129	0.000545	CbGpPWpGaD
Rasagiline—BCL2—Immune System—C3—glaucoma	0.000125	0.000526	CbGpPWpGaD
Rasagiline—Nausea—Timolol—glaucoma	0.000123	0.000199	CcSEcCtD
Rasagiline—BCL2—Immune System—BCL2L1—glaucoma	0.000119	0.000503	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—glaucoma	0.000112	0.000473	CbGpPWpGaD
Rasagiline—BCL2—Immune System—BAD—glaucoma	0.000108	0.000456	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—glaucoma	9.93e-05	0.000418	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—glaucoma	9.25e-05	0.00039	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CAV1—glaucoma	9.16e-05	0.000386	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA1—glaucoma	8.17e-05	0.000344	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CTSA—glaucoma	7.91e-05	0.000333	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDKN1B—glaucoma	7.54e-05	0.000318	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA2—glaucoma	7.47e-05	0.000315	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.3e-05	0.000308	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.3e-05	0.000308	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—glaucoma	6.93e-05	0.000292	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—glaucoma	6.34e-05	0.000267	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TXN—glaucoma	5.27e-05	0.000222	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.8e-05	0.000202	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.76e-05	0.000201	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTT1—glaucoma	4.08e-05	0.000172	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.29e-05	0.000139	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP1B1—glaucoma	3.25e-05	0.000137	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCA1—glaucoma	3.25e-05	0.000137	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—glaucoma	2.6e-05	0.00011	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—glaucoma	2.3e-05	9.68e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—glaucoma	2.14e-05	9.01e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAV1—glaucoma	2.12e-05	8.93e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—glaucoma	1.6e-05	6.75e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—glaucoma	1.47e-05	6.18e-05	CbGpPWpGaD
